Notably, and in contrast to the Add‐Tau cohort, we observed a negative association between hypertension and EC tau in the Aβ+ group when no path constraints were applied (β = −0.32, 95% CI: −0.60 to −0.05, p = .022). The gene discussed is MAPT; the disease is Hypertension.